ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

The Health Benefits of Manuka Honey

Increase Your Magnesium Intake

Vitamin D supplementation could ease IBS symptoms

Top Tips to Boost Your Immunity

11 Amazing Health Benefits of Using Baking Soda

Nicotinamide riboside shows promise for treatment of Alzheimer’s disease

Exercise, calcium, vitamin D, and other factors linked with fewer injurious falls

Vitamin D3 Is a Powerhouse for Your Heart

Rhodiola — A Powerful Adaptogen That Boosts Vitality and Performance, Eases Depression and Combats B...

Curcumin Supplementation May Impart Long-Term Cognitive Benefits

 
Print Page
Email Article

New TNF-Alpha Inhibitor for Rheumatoid Arthritis

  [ 11 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 27, 2002




Isis Pharmaceuticals, Inc. announced it has initiated a Phase II clinical trial of ISIS 104838, an inhibitor of tumor necrosis factor-alpha (TNF-alpha), in rheumatoid arthritis (RA).

The Phase II clinical trial will evaluate the safety and efficacy of ISIS in RA when administered by subcutaneous injection (SQ) for three months. This is the second Phase II study of ISIS currently in progress.

TNF-alpha is a naturally occurring cytokine that is involved in the development and progression of many inflammatory diseases, including RA. The double-masked, placebo-controlled, randomized Phase II study is planned to enroll 160 people with RA at 25 sites in the U.S. and Canada.

Three dosing regimens will be examined in this study: ISIS injections twice a week, once a week or once every other week. The primary endpoint in the study is improvement in American College of Rheumatology (ACR) response criteria, which measures improvement in patient and professional reported disease severity and activity.

"We are pleased to begin the second study of ISIS in people with rheumatoid arthritis, and to move forward with the clinical development of our new generation of antisense drugs. The initial Phase II trial, which began last November, is studying ISIS drug concentrations in tissue and blood as well as the drug's ability to reduce TNF-alpha levels. This new trial will be the first to provide efficacy information about ISIS in RA. We will use the combined results from the two studies to direct our future development plans with this drug," said F. Andrew Dorr, M.D., Isis Vice President and Chief Medical Officer.

Isis' first Phase II clinical trial of ISIS is evaluating the biological effect of TNF-alpha inhibition by ISIS in 20 RA patients over a four-week treatment period.

Phase I trials of intravenous infusion and SQ administration of ISIS demonstrated enhanced tolerability, duration of effect and dosing convenience compared with first-generation drugs.





Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Optimized Curcumin Longvida® FibroSleep™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get Energized with Malic Acid & Magnesium
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Block Acid Reflux to Prevent Esophageal Problems! Block Acid Reflux to Prevent Esophageal Problems!
The Fibromyalgia and Glutathione Link The Fibromyalgia and Glutathione Link
Vital Molecule Increases Cellular Energy and Improves Cognitive Function Vital Molecule Increases Cellular Energy and Improves Cognitive Function
Can Glycine + Amino Acids Be the Secret to Deep, Rejuvenating Sleep? Can Glycine + Amino Acids Be the Secret to Deep, Rejuvenating Sleep?
How One Tiny Molecule Turned into One Huge Health Breakthrough How One Tiny Molecule Turned into One Huge Health Breakthrough

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map